Reglagene

Thank you, Arizona! Last month, Reglagene’s CEO Richard Austin had the privilege of presenting at Arizona BioIndustry Association (AZBio)’s White Hat Conference, and we couldn’t be more grateful. Arizona has been the foundation of Reglagene’s growth, providing incredible talent, resources, and unwavering support along the way. We were truly honored to represent our home state and showcase our brain cancer therapy. #Reglagene #Biotech #Braincancer

Thank you, BioHouston, for the warm welcome! We are excited to join the Houston life sciences community and continue our mission of developing breakthrough therapies for brain diseases. We look forward to collaborating with BioHouston and its incredible network to accelerate innovation and improve patient outcomes. #biohouston #reglagene #braincancer

Grateful to have participated in the Rocky Mountain Life Sciences Investor and Partnering Conference in Breckenridge, Colorado! The Reglagene team had valuable conversations with industry leaders and investors, and CEO Richard Austin shared exciting updates on our lead asset in preclinical development. We're energized by the momentum and eager for what's next! #Reglagene #brainmets #braincancer #smallmolecules

Thank you, BioCentury Inc., Nashville! The Reglagene team had a great three days engaging in insightful discussions with key stakeholders and industry leaders. CEO Richard Austin took the stage to share exciting updates on our lead asset currently in preclinical development. #Reglagene #brainmets #braincancer #smallmolecules

We are excited to welcome Ben Maurey to Reglagene as our commercial-focused advisor on our Advisory Board. Ben comes to Reglagene after 8 years in the oncology space with a wide variety of roles and responsibilities. He started his career off in strategic consulting and eventually ran the Market Strategy Team at Vaniam Group, with his team focusing on early asset and market access strategy. Most recently, Ben ran market insights for early stage assets at Seagen and continued with the company after they were acquired by Pfizer. In addition to his commercial consulting and industry experience Ben has assisted with clinical/medical affairs strategy and was a Venture Partner at The Cancer Fund. #Biotech #Reglagene #talent

Thinking Small has lead to the biggest breakthrough. Yesterday, Reglagene's CEO Richard Austin presented at the BIO International Convention in San Diego. Here, he discussed how Reglagene's therapy has the unique ability to cross through the blood-brain barrier and fight brain cancer. Reach out to learn more! #BIO #braincancer #Reglagene

Thank you Angel Capital Association for selecting Reglagene as one of your Innovation Funders Showcase companies! CEO Richard Austin captivated the audience in Columbus, Ohio with a presentation on how "Thinking Small" has changed the way we think about treating brain cancer. #ACA #BrainCancer #Reglagene

Thrilled to have been part of Destination Startup hosted by Venture Partners at CU Boulder! Reglagene's CEO, Richard Austin, captivated a full room at 1:00 PM MDT with an exciting presentation focused on business and scientific milestones. A big thank you to Tech Launch Arizona for the invitation and to Stephen Miller for coordinating this fantastic event! #DestinationStartup #Biotech #CancerTherapy

Reglagene CEO Richard Austin and Desert Angels Tripp Shannon, CFA contributed to the “How I Met My Investor” panel at today’s Arizona BioPreneur Conference. Congrats to the Flinn Foundation and conference cochairs Nannon Roosa, PMP, CPA, FACMPE and Chris Yoo for putting on a top shelf event. #biotech #biopreneur #innovation

It's official! Reglagene is expanding to Houston, and our brain cancer therapy was accepted into the Texas Medical Center's Accelerator for Cancer Therapeutics 2024 Cohort. Read more here: https://lnkd.in/gsXDfq3e #TMC #Expansion #Biotech #clinicaldevelopment